Jenburkt Pharmaceuticals Investor Relations Material
Latest events
Q4 24/25
20 May, 2025
Q3 24/25
28 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jenburkt Pharmaceuticals Limited
Access all reports
Jenburkt Pharmaceuticals Limited is an Indian pharmaceutical company that manufactures and markets prescription medicines and over-the-counter products. It offers a range of therapeutic solutions in areas such as pain management, anti-infectives, and chronic disease treatments. The company serves domestic and international markets through a network of medical representatives and distribution partners. It is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
524731
Country
🇮🇳 India